.png){kind=logo}
Statistics
Total Visits
| Views | |
|---|---|
| Deucravacitinib, ... | 104 |
Total Visits per Month
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Deucravacitinib, ... | 0 | 4 | 37 | 19 | 28 | 15 | 1 |
File Downloads
| Views | |
|---|---|
| 7_2023_Deucravacitinib a tyrosine kinase 2 pseudokinase inhibitor protects human EndoC-betaH1_beta_cells against proinflammatory insults.pdf | 21 |
Top Country Views
| Views | |
|---|---|
| United States | 48 |
| Brazil | 7 |
| China | 7 |
| Vietnam | 6 |
| Argentina | 2 |
| Canada | 2 |
| Finland | 2 |
| India | 2 |
| Iraq | 2 |
| Turkey | 2 |
Top City Views
| Views | |
|---|---|
| Istanbul | 2 |
| Lappeenranta | 2 |
| San Jose | 2 |
| Tashkent | 2 |
| Vaughan | 2 |
| Amsterdam | 1 |
| Ashburn | 1 |
| Baghdad | 1 |
| Belo Horizonte | 1 |
| Dakar | 1 |